About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
NBR on TwitterMy Tweets
Subscribe to RSS
NBR Staff’s Posts
Tonight on Nightly Business Report, online retail sales surge as more shoppers sit at computers than stand on lines. Plus, our Market Monitor has three stocks he says investors should add to their holiday shopping lists.
Tonight: Thriving without regulation. A look at innovative companies and industries that are challenging the status quo.
Tonight on a special holiday edition of Nightly Business Report, thriving without regulation. A look at innovative companies and industries that are challenging the status quo.
Tonight: Are Americans ready for the holiday shopping season? New economic data sheds light on the health of the consumer.
Tonight on Nightly Business Report, are Americans ready for the holiday shopping season? New economic data sheds light on the health of the consumer.
Traditional department stores are opening up off-price chains in an effort to find growth.
Trade between the U.S. and Mexico is growing and that’s creating big business opportunities for companies that haul goods over the border.
Hampton Pearson has the details of the State Department’s travel warning.
Oil prices rise and bond yields inch lower after Turkey shot down a Russian fighter plane.
Tonight: Tensions are running high across the globe. We’ll take a look at the potential market impact.
Tonight on Nightly Business Report, tensions are running high across the globe. We’ll take a look at the potential market impact. And, the right questions to ask when you are selecting a brokerage firm so you can avoid hidden costs.
More women are becoming business owners and launching firms across the globe.
Julia Chatterley reports on the lockdown in Brussels.
Eamon Javers takes a look at how the White House is reacting to the Pfizer-Allergan merger.
Pfizer and Allergan are combining in a $160 billion deal, handing Pfizer a new address and creating a lot of controversy.